PolyPeptide Group AG ("PolyPeptide") (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ...
Samsung Biologics(207940) secured 97.98% equity in the tender offer for global peptide contract development and manufacturing ...
PolyPeptide Group AG ( ) has issued an update. PolyPeptide Group AG shareholders have approved all proposals put forward at an extraordinary general meeting in Baar, including the ...
The SMI ended Monday down 0.05%, while Deutsche Bank cut Novartis to sell and Samsung Biologics moved closer to full control of PolyPeptide.
Moscow, Russia--(Newsfile Corp. - August 16, 2023) - Polypeptide.ltd, a frontrunner in delivering exceptional peptide services, proudly announces a substantial expansion of its production capacity.
Swiss contract drugmaker PolyPeptide Group AG is attracting potential takeover interest from private equity firms including EQT AB and KKR & Co., people with knowledge of the matter said. Advent has ...
PolyPeptide Group AG announced that the shareholders approved all proposals by its board of directors at the extraordinary general meeting of shareholders held on October 26, 2026. In particular, the ...
Hosted on MSN
Samsung Biologics buys PolyPeptide in $1.81 billion deal to enter GLP-1 drug manufacturing
Samsung Biologics announced Sunday it would pay CHF 1.46 billion ($1.81 billion) in an all-cash tender offer to acquire PolyPeptide Group AG, a Swiss contract drug manufacturer that builds the ...
Kan Hyeong-woo is a staff reporter at The Korea Herald, South Korea’s leading English-language daily. Based in Seoul, he covers technology, business and industry, with reporting spanning the gaming, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results